Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

U.S. eyes emergency contraception grants if top court cuts abortion rights

Published 05/04/2022, 04:18 PM
Updated 05/04/2022, 07:16 PM
© Reuters. FILE PHOTO: The Supreme Court is pictured in Washington March 9, 2015. The Supreme Court on Monday threw out an appeals court decision that went against the University of Notre Dame over its religious objections to the Obamacare health law?s contraception

WASHINGTON (Reuters) -U.S. President Joe Biden's administration was looking at grants to help fund expanding access to emergency contraception as a possible response if the Supreme Court overturns a 1973 decision that legalized abortion nationwide, White House spokesperson Jen Psaki said on Wednesday.

"What we have done to date ... where we have seen restrictions ... is created for example the dire need grant awards, which provide funding to expand access to emergency contraception," Psaki told reporters in a press briefing.

A draft U.S. Supreme Court decision, leaked late on Monday, showed a majority of justices prepared to overturn the 1973 Roe v. Wade decision that protects abortion rights. The court on Tuesday confirmed the authenticity of the leaked document.

President Joe Biden appealed to voters on Tuesday to protect abortion rights by backing candidates who support them in November's mid-term elections.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.